Filing Details

Accession Number:
0001415889-22-000480
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-11 20:21:49
Reporting Period:
2022-01-10
Accepted Time:
2022-01-11 20:21:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750284 Olema Pharmaceuticals Inc. OLMA Pharmaceutical Preparations (2834) 300409740
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831215 Kinney Horn C/O Olema Pharmaceuticals, Inc.
512 2Nd Street, 4Th Floor
San Francisco CA 94107
Chief Business Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-10 5,251 $2.06 7,709 No 4 M Direct
Common Stock Disposition 2022-01-10 5,251 $6.85 2,458 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-01-10 5,251 $0.00 5,251 $2.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
152,289 2030-06-09 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  2. The weighted average sale price for the transaction reported was $6.85, and the range of prices were between $6.60 and $7.22. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.